维普期刊资源整合服务平台（V6.5）

24篇 您的检索式：作者名="Oechsle K"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Intraperitoneal VEGFinhibition using bevacizumab:a potential approach for the symptomatic treatment of malignant ascites显示文摘	Kobold S Hegewisch-Becker S Oechsle K		0，，：	1
2	Prospective comparison of fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma 显示文摘	Kollmannsberger C Oechsle K Dohmen BM	2002	Cancer2002，94，9：	1
3	Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites? 显示文摘	Kobold S Hegewisch-Becker S Oechsle K	2009	Oncologist2009，14，12：	1
4	Effects of exercise training programs on physical performance and quality of life in patients with metastatic lung cancer undergoing palliative chemotherapy-a study protocol显示文摘	Jensen W Oechsle K Baumann HI	2014	Contemp Clin Trials2014，37，1：	1
5	Intraperitoneal VEGF inhibition using bevacizumab:a potential approach for the symptomatic treatment of malignant ascites?显示文摘	Kobold S Hegewisch-Becker S Oechsle K	2009	Oncologist2009，14，12：	1
6	Global meaning and meaning-related life attitudes:exploring their role in predicting depression, anxiety, and demoralization in cancer patients 显示文摘	Vehling S Lehmann C Oechsle K	2011	Support Care Cancer2011，19，4：	1
7	Prognostic fac- tors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis显示文摘	Oechsle K Lange-Brock V Knaell A	2010	J Cancer Res Clin Oncol2010，136，11：	1
8	Intraperitoneal VEGF inhibition using bevacizumab: A potential approach for the symptomatic treatment of malignant ascites 显示文摘	Kobold S Hegewisch-Becker S Oechsle K	2009	Oncologist2009，14，12：	1
9	Clinical outcomes of point-of-care testing in the intervention radiology and invasive cardiology setting显示文摘	Nichols JH Kickler TS Dyer K Humbertson SK Cooper PC Maughan WL Oechsle DG	2000	Clin Chem2000，46，4：	1
10	Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis 显示文摘	Oechsle K Lange-Brock V Kruell A	2010	J Cancer Res Clin Oncol2010，136，：	1
11	Symptom bur- den in palliative care patients: perspectives of patients, their family caregivers, and their attending physicians显示文摘	Oechsle K Goerth K Bokemeyer C	2013	Support Care Cancer2013，21，7：	1
12	Treatment of brain metastases from germ cell tumors显示文摘	Oechsle K Bokemeyer C	2011	Hematol Oncol Clin North Am2011，25，3：	1
13	Anxiety and De- pression in Caregivers of Terminally Ill Cancer Patients: Impact on Their Perspective of the Patients'Symptom Bur- den显示文摘	Oechsle K Goerth K Bokemeyer C	2013	J Palliat Med2013，16，9：	1
14	Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors;a retrospective analysis显示文摘	OECHSLE K LANGE BROCK V KRUELL A	2010	J Cancer Res Clin Oncol2010，136，11：	1
15	Intraperitoneal VEGF inhibition using bevacizumab : a potential approach for the symptomatic treatment of malignant ascites?显示文摘	Kobold S Hegewisch-Becker S Oechsle K	2009	Oncologist2009，14，12：	1
16	Prognostic factors and treatment options in patients with leptomeningeal metastases of dif- ferent primary tumors: a retrospective analysis显示文摘	Oechsle K Lange-Brock V Kruell A	2010	J Cancer Res Clin Oncol2010，136，11：	1
17	Early predic- tion of treatment response to high dose salvage chemotherapy in patients with relapsed germ cell cancer using 18F-FDG PET显示文摘	Bokemeyer C Kollmannsgerger C Oechsle K	2002	Br J Cancer2002，86，4：	1
18	Relationship between symptom burden, distress, and sense of dignity in terminally ill cancer patients显示文摘	Oechsle K Wais MC Vehling S	2014	Journal of Pain and Symptom Management2014，48，3：	1
19	Intraperitoneal VEGF inhibition using bevacizumab:a potential approach for the symptomatic treatment of malignant ascites显示文摘	KOBOLD S HEGEWISCH-BECKER S OECHSLE K	2009	Oncologist2009，14，12：	1
20	Intraperitoneal VEGF inhibition using bevacizumab:a potential approach for the symptomatic treatment of malignant ascites显示文摘	Kobold S Hegewisch-Becker S Oechsle K		0，，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示